(The Familial Hypercholesterolemia Foundation) Individuals at high risk for cardiovascular events had more heart attacks, strokes and other cardiovascular events when they were unable to obtain their prescribed LDL-cholesterol lowering medication. In a new study in Circulation: Cardiovascular Quality and Outcomes, researchers with the FH Foundation found that individuals with familial hypercholesterolemia (FH) or atherosclerotic heart disease (ASCVD) whose PCSK9 inhibitors (PCSK9is) were rejected by their insurance plan had an immediate 16% increased risk of a cardiovascular event during the 12-month study period.
from EurekAlert! - Social and Behavioral Science https://ift.tt/2y51lwV
No comments:
Post a Comment